Pieris Pharmaceuticals, Inc. (PIRS)

Pieris Pharmaceuticals Revenue

Pieris Pharmaceuticals had revenue of $1.35M in the twelve months ending September 30, 2024, down -97.15% year-over-year. In the year 2023, Pieris Pharmaceuticals had annual revenue of $42.81M with 65.28% growth.

• Revenue (ttm): $1.35M
• Revenue Growth: -97.15%
• P/S Ratio: 15.07
• Revenue / Employee: $27,040
• Employees: 50
• Market Cap: 21.20M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	42.81M	16.91M	65.28%
Dec 31, 2022	25.90M	-5.52M	-17.56%
Dec 31, 2021	31.42M	2.10M	7.14%
Dec 31, 2020	29.32M	-16.96M	-36.64%
Dec 31, 2019	46.28M	17.18M	59.03%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.